Back to Search Start Over

Social network distribution of syphilis self-testing among men who have sex with men in China: study protocol for a cluster randomized control trial.

Authors :
Wang, Yajie
Zhang, Wei
Bao, Dongping
Ong, Jason J.
Tucker, Joseph D.
Ye, Rouxuan
Zheng, Heping
Yang, Bin
Wang, Cheng
Source :
BMC Infectious Diseases. 5/27/2021, Vol. 21 Issue 1, p1-9. 9p.
Publication Year :
2021

Abstract

<bold>Background: </bold>Syphilis is a common sexually transmitted infection (STI) among men who have sex with men (MSM). Increasing syphilis testing is important to syphilis control. However, in low- and middle-income countries like China, syphilis testing rates remain low among MSM. We describe a randomized controlled trial protocol to examine the effectiveness of social network distribution approaches of syphilis self-testing among MSM in China.<bold>Methods: </bold>We will recruit index and alter MSM. Indexes will be eligible if they: are born biologically male; aged 18 years or above; ever had sex with another man; are willing to distribute syphilis testing packages or referral links to their alters; and willing to provide personal contact information for future follow-up. Three hundred MSM will be recruited and randomly assigned in a 1:1:1 ratio into three arms: standard of care (control arm); standard syphilis self-testing (SST) delivery arm; and referral link SST delivery arm. Indexes will distribute SST packages or referral links to encourage alters to receive syphilis testing. All indexes will complete a baseline survey and a 3-month follow-up survey. Syphilis self-test results will be determined by photo verification via a digital platform. The primary outcome is the mean number of alters who returned verified syphilis testing results per index in each arm.<bold>Discussion: </bold>The trial findings will provide practical implications in strengthening syphilis self-testing distribution and increasing syphilis testing uptake among MSM in China. This study also empowers MSM community in expanding syphilis testing by using their own social network.<bold>Trial Registration: </bold>Chinese Clinical Trial Registry, ChiCTR2000036988 . Registered 26 August 2020 - Retrospectively registered. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14712334
Volume :
21
Issue :
1
Database :
Academic Search Index
Journal :
BMC Infectious Diseases
Publication Type :
Academic Journal
Accession number :
150537943
Full Text :
https://doi.org/10.1186/s12879-021-06137-0